Literature DB >> 28382419

A multicenter study on the diagnostic significance of a single cerebrospinal fluid IgG band.

Diana Ferraro1, Diego Franciotta2, Roberta Bedin3, Claudio Solaro4, Eleonora Cocco5, Mario Santangelo6, Paolo Immovilli7, Alberto Gajofatto8, Massimiliano Calabrese8, Massimiliano Di Filippo9, Riccardo Orlandi8, Anna Maria Simone3, Francesca Vitetta3, Elisabetta Capello10, Debora Giunti10, Alessandra Murialdo11, Jessica Frau5, Sara Mariotto8, Antongiulio Gallina9, Claudio Gasperini12, Patrizia Sola3.   

Abstract

The analysis of paired cerebrospinal fluid (CSF) and serum samples with isolectric focusing (IEF) can yield different patterns which can be of aid in the differential diagnosis of central nervous system (CNS) disorders. Rarely, a single CSF-restricted IgG band, which is not included within these patterns, can be detected in association with inflammatory disorders, multiple sclerosis (MS) above all. However, the diagnostic meaning of this abnormality is still uncertain. The main aim of our multicenter study was to establish the frequency and disease associations of single CSF IgG bands. Differences in the CSF profiles between MS and other diseases, and the follow-up patterns were also evaluated. Medical records of patients who underwent CSF analysis, which included IEF, over a 11.5-year period were retrospectively scrutinized at the participating centers, which used similar IEF techniques. One hundred and fifty-one of 9422 CSF reports (1.6%) showed single CSF-restricted IgG bands. Of the 129 patients with a definite diagnosis, 58.2% had CNS inflammatory-demyelinating diseases (the most frequent being MS: 21.7%), 6.2% tumours, 5.4% inflammatory peripheral nervous system diseases and 30.2% miscellaneous diseases. At follow-up, 3 out of the 10 patients with a repeated CSF analysis had developed an oligoclonal band pattern. Our findings indicate that single CSF IgG bands tend to associate with diseases characterized by the involvement of intrathecal humoral immune responses, and strongly support the notion that this abnormality should be regularly reported, thus alerting clinicians of possible inflammatory disorders of the CNS.

Entities:  

Keywords:  Cerebrospinal fluid; Isoelectric focusing; Multiple sclerosis; Single IgG band

Mesh:

Substances:

Year:  2017        PMID: 28382419     DOI: 10.1007/s00415-017-8480-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  20 in total

1.  The clinical significance of an intrathecal monoclonal immunoglobulin band: a follow-up study.

Authors:  Diego Franciotta; Elisabetta Zardini; Francesco Lolli
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910

2.  The influence of disease duration, clinical course, and immunosuppressive therapy on the synthesis of intrathecal oligoclonal IgG bands in multiple sclerosis.

Authors:  Markus Axelsson; Niklas Mattsson; Clas Malmeström; Henrik Zetterberg; Jan Lycke
Journal:  J Neuroimmunol       Date:  2013-09-18       Impact factor: 3.478

Review 3.  Autoimmune disorders affecting both the central and peripheral nervous system.

Authors:  Christoph Kamm; Uwe K Zettl
Journal:  Autoimmun Rev       Date:  2011-05-18       Impact factor: 9.754

4.  Interpretation of single band patterns in CSF protein electrophoresis.

Authors:  B H Bass; H Armstrong; B Weinshenker; G C Ebers; J H Noseworthy; G P Rice
Journal:  Can J Neurol Sci       Date:  1988-02       Impact factor: 2.104

5.  Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement.

Authors:  Mark S Freedman; Edward J Thompson; Florian Deisenhammer; Gavin Giovannoni; Guy Grimsley; Geoffrey Keir; Sten Ohman; Michael K Racke; Mohammad Sharief; Christian J M Sindic; Finn Sellebjerg; Wallace W Tourtellotte
Journal:  Arch Neurol       Date:  2005-06

6.  Sequential changes in oligoclonal patterns during the course of multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; P Rudge
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-06       Impact factor: 10.154

Review 7.  An update on the use of cerebrospinal fluid analysis as a diagnostic tool in multiple sclerosis.

Authors:  Matteo Gastaldi; Elisabetta Zardini; Diego Franciotta
Journal:  Expert Rev Mol Diagn       Date:  2016-12-02       Impact factor: 5.225

Review 8.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

9.  Utility of isoelectric focusing of cerebrospinal fluid and serum on agarose evaluated for neurological patients.

Authors:  H Link; V Kostulas
Journal:  Clin Chem       Date:  1983-05       Impact factor: 8.327

10.  Central nervous system expression of a monoclonal paraprotein in a chronic lymphocytic leukemia patient.

Authors:  P Ruiz; M Moezzi; W Chamizo; P Ganjei; C C Whitcomb; L C Rey
Journal:  Acta Haematol       Date:  1992       Impact factor: 2.195

View more
  2 in total

Review 1.  Cerebrospinal fluid analysis and the determination of oligoclonal bands.

Authors:  Matteo Gastaldi; Elisabetta Zardini; Rosaria Leante; Maddalena Ruggieri; Gianna Costa; Eleonora Cocco; Giovanna De Luca; Ivana Cataldo; Tiziana Biagioli; Clara Ballerini; Massimiliano Castellazzi; Enrico Fainardi; Paola Pettini; Mauro Zaffaroni; Debora Giunti; Elisabetta Capello; Gaetano Bernardi; Emilio Ciusani; Claudia Giannotta; Eduardo Nobile-Orazio; Elena Bazzigaluppi; Gabriella Passerini; Roberta Bedin; Patrizia Sola; Rinaldo Brivio; Guido Cavaletti; Arianna Sala; Antonio Bertolotto; Gaetano Desina; Maurizio A Leone; Sara Mariotto; Sergio Ferrari; Andreina Paternoster; Davide Giavarina; Francesco Lolli; Diego Franciotta
Journal:  Neurol Sci       Date:  2017-10       Impact factor: 3.307

2.  The clinical significance of single or double bands in cerebrospinal fluid isoelectric focusing. A retrospective study and systematic review.

Authors:  Harald Hegen; Anne Zinganell; Michael Auer; Florian Deisenhammer
Journal:  PLoS One       Date:  2019-04-15       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.